-
Gonococcal Infections, CDC's Updated Treatment; Head Lice Malathion First-Line Treatment; Statins, May Cut the Risk of Cataracts; FDA Actions
-
-
-
-
-
Hepatitis C virus (HCV) infection results in both acute and chronic hepatitis.
-
Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been in development by Pfizer for nearly 15 years.
-
Even though multidrug-resistant (MDR) and extensively drug resistant (XDR) TB are at extremely low levels in the United States, the cost of a single infection is staggering, Julie Gerberding, MD, MPH, director for the Centers for Disease Control and Prevention recently told Congress.
-
A review of evaluable multidrug-resistant tuberculosis (MDR-TB) cases that occurred in the United States from 1993 to 2006 found that 49 (3%) met the definition for extensively drug-resistant XDR-TB cases. Of those, 17 (35%) were reported during 2000-2006, the Centers for Disease Control and Prevention reports.
-
If extensively drug-resistant tuberculosis (XDR-TB) emerges to become an infection control threat in the nation's hospitals, the lessons learned from past outbreaks will prove invaluable.
